Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

Current Cancer Drug Targets - United Arab Emirates
doi 10.2174/156800911793743600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

The Human Equilibrative Nucleoside Transporter Protein1 (Hent1) Is a Predict /Prognostic Factor in Resected Pancreatic Cancer Patients

Biomedical Journal of Scientific & Technical Research
2018English

The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated With Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Mutation of Trp29of Human Equilibrative Nucleoside Transporter 1 Alters Affinity for Coronary Vasodilator Drugs and Nucleoside Selectivity

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2008English

Chimeric Constructs Between Human and Rat Equilibrative Nucleoside Transporters (hENT1 and rENT1) Reveal hENT1 Structural Domains Interacting With Coronary Vasoactive Drugs

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

A Nomogram to Predict Overall Survival for Biliary Tract Cancer

Cancer Management and Research
Oncology
2018English

Histological Complete Response in a Patient With Advanced Biliary Tract Cancer Treated by Gemcitabine/Cisplatin/S-1 Combination Chemotherapy: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Identification of TIGAR in the Equilibrative Nucleoside Transporter 2-Mediated Response to Fludarabine in Chronic Lymphocytic Leukemia Cells

Haematologica
Hematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy